Tauopathy in the young autistic brain: novel biomarker and therapeutic target
Iris Grigg(Tel Aviv University), Illana Gozes(Tel Aviv University), Nikolaos Grigoriadis(Unknown), Yanina Ivashko‐Pachima(Tel Aviv University), Zlatko Marušić(University Hospital Centre Zagreb), Tom Aharon Hait(Tel Aviv University), Roza Lagoudaki(Aristotle University of Thessaloniki), R. Frank Kooy(University of Antwerp), Mirna Aničić(University Hospital Centre Zagreb), Anke Van Dijck(University of Antwerp), Olga Touloumi, Jurica Vuković(University Hospital Centre Zagreb), Vlasta Korenková(Czech Academy of Sciences, Institute of Biotechnology)
Cited by 108
Related Papers
Where are Europe’s last primary forests?
|Diversity and Distributions|2018|454
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
|Journal of Neurology Neurosurgery & Psychiatry|2014|355
Neuroprotection and Immunomodulation With Mesenchymal Stem Cells in Chronic Experimental Autoimmune Encephalomyelitis
|Archives of Neurology|2008|338
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293
Diagnosis and classification of optic neuritis
|The Lancet Neurology|2022|290